SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-197820
Filing Date
2023-07-28
Accepted
2023-07-28 17:17:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d454547d424b5.htm 424B5 547020
2 GRAPHIC g454547g01a01.jpg GRAPHIC 46859
3 GRAPHIC g454547g01p41.jpg GRAPHIC 48293
  Complete submission text file 0001193125-23-197820.txt   670913
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-258702 | Film No.: 231124172
SIC: 2834 Pharmaceutical Preparations